Renal denervation for hypertension

Muntner, P. et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA 324, 1190–1200 (2020).

Article  PubMed  Google Scholar 

Ritchey, M. D. et al. Potential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guideline. J. Clin. Hypertens. 20, 1377–1391 (2018).

Article  Google Scholar 

Strauch, B. et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J. Hypertens. 31, 2455–2461 (2013).

Article  CAS  PubMed  Google Scholar 

Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J. & Burnier, M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336, 1114–1117 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Jung, O. et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J. Hypertens. 31, 766–774 (2013).

Article  CAS  PubMed  Google Scholar 

Brinker, S. et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J. Am. Coll. Cardiol. 63, 834–835 (2014).

Article  PubMed  Google Scholar 

Ceral, J. et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens. Res. 34, 87–90 (2011).

Article  CAS  PubMed  Google Scholar 

Smithwick, R. H. & Thompson, J. E. Splanchnicectomy for essential hypertension: results in 1,266 cases. J. Am. Med. Assoc. 152, 1501–1504 (1953).

Article  CAS  PubMed  Google Scholar 

Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E. & Esler, M. D. Renal sympathetic-nerve ablation for uncontrolled hypertension. N. Engl. J. Med. 361, 932–934 (2009).

Article  CAS  PubMed  Google Scholar 

Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275–1281 (2009).

Article  PubMed  Google Scholar 

Azizi, M. et al. Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure at 6 months following medication escalation: the RADIANCE Clinical Trial Program. Circulation 149, 747–759 (2023).

Article  PubMed  Google Scholar 

Bhatt, D. L. et al. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet 400, 1405–1416 (2022).

Article  PubMed  Google Scholar 

Townsend, R. R. et al. Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation. EuroIntervention 16, 89–96 (2020).

Article  PubMed  Google Scholar 

Rader, F. et al. Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial. EuroIntervention 18, e677–e685 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Zhou, B. et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957–980 (2021).

Article  Google Scholar 

Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Choudhry, N. K. et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension 79, e1–e14 (2022).

Article  CAS  PubMed  Google Scholar 

Durand, H. et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J. Hypertens. 35, 2346–2357 (2017).

Article  CAS  PubMed  Google Scholar 

Choudhry, N. K., Denberg, T. D., Qaseem, A. & Clinical Guidelines Committee of American College of Physicians. Improving adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann. Intern. Med. 164, 41–49 (2016).

Article  PubMed  Google Scholar 

Yang, W. et al. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr. Med. Res. Opin. 26, 2065–2076 (2010).

Article  CAS  PubMed  Google Scholar 

Fisher, N. D. L. & Mahfoud, F. Medication adherence in hypertension: lessons learned from renal denervation trials. Eur. J. Prev. Cardiol. 30, 34–36 (2023).

Article  PubMed  Google Scholar 

Azizi, M. et al. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial. Circulation 134, 847–857 (2016).

Article  CAS  PubMed  Google Scholar 

Azizi, M. et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385, 1957–1965 (2015).

Article  PubMed  Google Scholar 

Kandzari, D. E. et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391, 2346–2355 (2018).

Article  PubMed  Google Scholar 

Azizi, M. et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet 397, 2476–2486 (2021).

Article  CAS  PubMed  Google Scholar 

DiBona, G. F. & Kopp, U. C. Neural control of renal function. Physiol. Rev. 77, 75–197 (1997).

Article  CAS  PubMed  Google Scholar 

Esler, M. et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11, 3–20 (1988).

Article  CAS  PubMed  Google Scholar 

Sakakura, K. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J. Am. Coll. Cardiol. 64, 635–643 (2014).

Article  PubMed  Google Scholar 

Mahfoud, F., Edelman, E. R. & Bohm, M. Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy? J. Am. Coll. Cardiol. 64, 644–646 (2014).

Article  PubMed  Google Scholar 

Struthoff, H. et al. Histological examination of renal nerve distribution, density, and function in humans. EuroIntervention 19, 612–620 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Tzafriri, A. R. Innervation patterns may limit response to endovascular renal denervation. J. Am. Coll. Cardiol. 64, 1079–1087 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Mahfoud, F. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J. Am. Coll. Cardiol. 66, 1766–1775 (2015).

Article  PubMed  Google Scholar 

Kandzari, D. E. et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J. Am. Coll. Cardiol. 82, 1809–1823 (2023).

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif